Dr. Rajeev Saggar - 10 Jul 2026 Form 4 Insider Report for Liquidia Corp (LQDA)

Reporting relationship: Chief Medical Officer
Issuer ticker: LQDA
Reported as of: 10 Jul 2026
Net transaction value: -$709,816
SEC form: 4
Accepted by SEC: 14 Jul 2026, 20:02:45 UTC
Prior SEC filing: 14 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Dr. Rajeev Saggar

Key filing fact

Dr. Rajeev Saggar filed Form 4 for Liquidia Corp (LQDA) on 14 Jul 2026.

Key facts

This page summarizes Dr. Rajeev Saggar's Form 4 filing for Liquidia Corp (LQDA).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 Jul 2026, 20:02.

Change

Previous filing in this sequence was filed on 14 Apr 2026.
Current net transaction value: -$709,816.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001935638 Primary reporting owner

Saggar Rajeev

Relationship: Chief Medical Officer
Address: 419 DAVIS DRIVE, SUITE 100, MORRISVILLE
Signature: /s/ Dr. Rajeev Saggar
Signature date: 14 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LQDA transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,531
Change %: +2%
Price
Shares after: 177,238
Date: 10 Jul 2026
Ownership: Direct
Footnotes: F1, F2, F3

LQDA transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,487
Change %: +2.5%
Price
Shares after: 181,725
Date: 10 Jul 2026
Ownership: Direct
Footnotes: F1, F3, F4

LQDA transaction

Common Stock

Sale

Transaction value: $50,187
Shares: -703
Change %: -0.39%
Price: $71.39
Shares after: 181,022
Date: 13 Jul 2026
Ownership: Direct
Footnotes: F1, F3, F5, F6

LQDA transaction

Common Stock

Sale

Transaction value: $659,629
Shares: -9,223
Change %: -5.1%
Price: $71.52
Shares after: 171,799
Date: 13 Jul 2026
Ownership: Direct
Footnotes: F1, F3, F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LQDA transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
Shares: -3,531
Change %: -14%
Price: $0.000000^*
Shares after: 21,184
Date: 10 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,531
Exercise price
Footnotes: F1

LQDA transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
Shares: -4,487
Change %: -9.1%
Price: $0.000000^*
Shares after: 44,862
Date: 10 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,487
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Performance stock units ("PSUs") convert into common stock on a one-for-one basis.

Footnote F2

On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 35,308 have vested as of the date of this Form 4.

Footnote F3

Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Footnote F4

On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 26,918 have vested as of the date of this Form 4.

Footnote F5

Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.

Footnote F6

These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.